Hikma To Pay Up $150m In US Opioid Settlement Framework

Company Faced Claims Of Failing To Report Suspicious Opioid Orders From 2006 To 2021

 
• By Urtė Fultinavičiūtė
  
US flag with crushed tablets from bottle
The agreement will resolve the “vast majority” of Hikma’s opioid-related lawsuits • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business